流动负债 更改
3i Infrastructure GBP 18M 15M 2025-12
AstraZeneca USD 30.62B 3.44B 2025-12
GlaxoSmithKline GBP 21.39B 57M 2025-12
Hikma Pharmaceutical USD 1.45B 603M 2025-12